Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer

Fountzilas, G; Ciuleanu, E; Dafni, U; Plataniotis, G; Kalogera-Fountzila, A; Samantas, E; Athanassiou, E; Tzitzikas, J; Ciuleanu, T; Nikolaou, A; Pantelakos, P; Zaraboukas, T; Zamboglou, N; Daniilidis, J; Ghilezan, N

dc.contributor.author	Fountzilas, G	en
dc.contributor.author	Ciuleanu, E	en
dc.contributor.author	Dafni, U	en
dc.contributor.author	Plataniotis, G	en
dc.contributor.author	Kalogera-Fountzila, A	en
dc.contributor.author	Samantas, E	en
dc.contributor.author	Athanassiou, E	en
dc.contributor.author	Tzitzikas, J	en
dc.contributor.author	Ciuleanu, T	en
dc.contributor.author	Nikolaou, A	en
dc.contributor.author	Pantelakos, P	en
dc.contributor.author	Zaraboukas, T	en
dc.contributor.author	Zamboglou, N	en
dc.contributor.author	Daniilidis, J	en
dc.contributor.author	Ghilezan, N	en
dc.date.accessioned	2014-03-01T01:53:18Z
dc.date.available	2014-03-01T01:53:18Z
dc.date.issued	2004	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/26942
dc.subject	Head and Neck Neoplasm	en
dc.subject	Overall Survival	en
dc.subject	Survival Rate	en
dc.subject	Complete Response	en
dc.subject	Head and Neck Cancer	en
dc.subject	Time To Progression	en
dc.title	Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer	en
heal.type	journalArticle	en
heal.identifier.primary	10.1385/MO:21:2:095	en
heal.identifier.secondary	http://dx.doi.org/10.1385/MO:21:2:095	en
heal.publicationDate	2004	en
heal.abstract	The primary objective of the present randomized phase III trial was to compare the 3-yr survival rate of patients treated with standard fractionated radiotherapy (RT) alone or with the same RT concomitantly with cisplatin (DDP) or carboplatin (Cb). From January 1995 until July 1999, 124 patients with histologically proven locally advanced non-nasopharyngeal head and neck cancer (HNC) were randomized to	en
heal.journalName	Medical Oncology	en
dc.identifier.doi	10.1385/MO:21:2:095	en